Back
Penumbra 10K Form
Buy
51
PEN
Penumbra
Last Price:
$277.30
Seasonality Move:
3.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-03 | 10Q | PEN/Penumbra Quarterly |
| 2020-05-07 | 10Q | PEN/Penumbra Quarterly |
| 2020-02-26 | 10K | PEN/Penumbra Annual |
| 2019-11-07 | 10Q | PEN/Penumbra Quarterly |
| 2019-08-06 | 10Q | PEN/Penumbra Quarterly |
| 2019-05-07 | 10Q | PEN/Penumbra Quarterly |
Receive PEN News And Ratings
See the #1 stock for the next 7 days that we like better than PEN
PEN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.2B |
|---|---|
| Cash Flow: | $45.7M |
| Price / Cash Flow: | 74.52 |
| Annual Sales: | $29.90 |
| Price / Book: | 9.32 |
Profitability
| EPS (TTM): | 0.34000 |
|---|---|
| Net Income (TTM): | $14M |
| Gross Margin: | $755M |
| Return on Equity: | 1.21% |
| Return on Assets: | 0.91% |
Penumbra Earnings Forecast
Key Penumbra Financial Ratios
-
The Gross Profit Margin over the past 13 years for PEN is 63.20%.
-
The Selling, General & Administrative Expenses for PEN have been equal to 48.05% of Gross Profit Margin.
-
The Research & Development expenses have been 7.93% of Revenue.
-
The Interest Expense is 10.12% of Operating Income.
-
The Net Earning history of PEN is 1.17% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 6 years.
Penumbra Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | PEN |
| CUSIP: | 70975L |
| Website: | penumbrainc.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.01 |
| Quick Ratio: | 3.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 770.42 |
|---|---|
| Forward P/E Ratio: | 56.16 |